Evidence map›Paper›PMID 35346363›Full record

ReviewCell & bioscience2022

DNA in extracellular vesicles: from evolution to its current application in health and disease.

Jamal Ghanam, Venkatesh Kumar Chetty, Lennart Barthel, Dirk Reinhardt, Peter-Friedrich Hoyer, Basant Kumar Thakur

Abstract readReview
In one paragraph

Review in Cell & bioscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Selective DNA encapsulation in extracellular vesicles ofExtracellular vesicles and circulating nucleic acids · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jamal GhanamDepartment of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, 45147, Essen, Germany.
Venkatesh Kumar ChettyDepartment of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, 45147, Essen, Germany.
Lennart BarthelDepartment of Neurosurgery and Spine Surgery, Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, 45147, Essen, Germany.
Dirk ReinhardtDepartment of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, 45147, Essen, Germany.
Peter-Friedrich HoyerDepartment of Pediatrics II, University Hospital Essen, University of Duisburg-Essen, 45147, Essen, Germany.
Basant Kumar ThakurDepartment of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, 45147, Essen, Germany. basant-kumar.thakur@uk-essen.de.ORCID http://orcid.org/0000-0001-7013-7895

Funding

Deutsche Forschungsgemeinschaft DFG D/106-21742Deutsche Kinderkrebsstiftung DKS 2018.17
6 · The paper itself

Abstract

Extracellular vesicle (EV) secretion is a highly conserved evolutionary trait in all organisms in the three domains of life. The packaging and release of EVs appears to be a bulk-flow process which takes place mainly under extreme conditions. EVs participate in horizontal gene transfer, which supports the survival of prokaryotic and eukaryotic microbes. In higher eukaryotes, almost all cells secrete a heterogeneous population of EVs loaded with various biomolecules. EV secretion is typically higher in cancer microenvironments, promoting tumor progression and metastasis. EVs are now recognized as additional mediators of autocrine and paracrine communication in health and disease. In this context, proteins and RNAs have been studied the most, but extracellular vesicle DNA (EV-DNA) has started to gain in importance in the last few years. In this review, we summarize new findings related to the loading mechanism(s), localization, and post-shedding function of EV-DNA. We also discuss the feasibility of using EV-DNA as a biomarker when performing a liquid biopsy, at the same time emphasizing the lack of data from clinical trials in this regard. Finally, we outline the potential of EV-DNA uptake and its interaction with the host genome as a promising tool for understanding the mechanisms of cancer evolution.

Identifiers

PMID35346363
PMCPMC8961894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.